Clinically, high GPR132 levels correlate with increased M2 macrophages and poor outcomes in BC patients, highlighting the lactate-GPR132axis as a key metastasis driver and potential therapeutic target (Chen et al. 2017). The gene discussed is GPR132; the disease is breast cancer.